Request Trial
shutterstock_1569359980_sundry_photography
Sundry Photography / Shutterstock.com
31 March 2022Big PharmaMuireann Bolger

Gilead loses bid to quash parallel antitrust HIV lawsuit

Gilead Sciences has failed to prevent insurer Aetna from pursuing its lawsuit in a US state court, as it faces a spate of antitrust complaints alleging that it used pay-for-delay deals to maintain the high costs of HIV drugs.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
The clinical trial dilemma: Navigating European practice
27 November 2025   Clinical trials create a patent paradox. With EPO case law rapidly reshaping the 'expectation of success' test—most recently T136/24—the line between innovation and obviousness is blurred. Amanda Simons of J A Kemp offers drafting strategies to secure protection for your downstream innovations.
Big Pharma
Report reveals surge of AI adoption in IP but lawyers remain cautious
20 November 2025   A new report from Clarivate highlights a jump in the tech’s adoption among IP professionals over the past two years, as well as concerns over governance.
Big Pharma
Sun Pharma and BMS lead 2025 ANDA litigation
10 November 2025   According to new research, generic and brand-name pharma companies are ramping up ANDA litigation with Sun Pharma and Bristol Myers Squibb leading the charge.


Editor's picks

Deadline extended: Who are the world’s best in-house counsel?
Europe
Deadline extended: Who are the world’s best in-house counsel?
9 January 2026

Editor's picks

Europe
Deadline extended: Who are the world’s best in-house counsel?
9 January 2026
Americas
SCOTUS shuts the door on Entresto ‘after-arising technology’ review
17 December 2025
Europe
Abbott appeals ‘baffling’ decision in glucose monitoring device feud
16 December 2025
Americas
Teva scrubs 200-plus Orange Book patents after FTC turns the screw
11 December 2025
Americas
US govt backs Hikma over ‘skinny label’ rules
9 December 2025
Big Pharma
The clinical trial dilemma: Navigating European practice
27 November 2025

More features

From migraine drugs to COVID vaccine spats, US lawsuits pile up
Deadline extended: Who are the world’s best in-house counsel?
‘All voices must be heard’: New CIPA president sets out plans for 2026
Insulin pump rivals face off in major trade secrets dispute hearing
Bayer enters COVID-19 vaccine row with three suits against major drugmakers
Arnold & Porter loses another regulatory partner to growing rival
CIPA’s outgoing president: UK rejoining the UPC needs ‘support from business’
Merchant & Gould hires 13 attorneys to open new Boston office